Tyra Biosciences (TYRA) Return on Capital Employed (2021 - 2026)
Tyra Biosciences (TYRA) posted Return on Capital Employed of 43.56% for Q1 2026, up 10.05% on a QoQ basis from 48.43% in Q4 2025, and down 1004.0% year-over-year from 4.82% in Q1 2025.
Tyra Biosciences (TYRA) Return on Capital Employed (2021 - 2026) Analysis & Trends
Tyra Biosciences' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 43.56% for Q1 2026.
- Quarterly Return on Capital Employed fell 1004.0% year-over-year to 43.56% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 43.56% (down 1004.0% YoY) and the FY2025 annual result came in at 43.53%, down 634.0% from the prior year.
- Return on Capital Employed was 43.56% for Q1 2026 at Tyra Biosciences, up from 48.43% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 12.39% in Q1 2022 and bottomed at 48.43% in Q4 2025.
- A 5-year average of 29.35% and a median of 28.68% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 773 bps — and 2025, when it plunged 1928 bps.
- Tyra Biosciences' Return on Capital Employed stood at 22.2% in 2022, then tumbled by 66 bps to 36.88% in 2023, then advanced by 21 bps to 29.15% in 2024, then tumbled by 66 bps to 48.43% in 2025, then grew by 10 bps to 43.56% in 2026.
- Business Quant data shows TYRA's Return on Capital Employed at 43.56% in Q1 2026, 48.43% in Q4 2025, and 42.59% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | -43.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.56% |
| Dec 31, 2025 | -48.43% |
| Sep 30, 2025 | -42.59% |
| Jun 30, 2025 | -38.17% |
| Mar 31, 2025 | -33.52% |
| Dec 31, 2024 | -29.15% |
| Sep 30, 2024 | -26.75% |
| Jun 30, 2024 | -24.59% |
| Mar 31, 2024 | -28.68% |
| Dec 31, 2023 | -36.88% |
| Sep 30, 2023 | -29.62% |
| Jun 30, 2023 | -23.88% |
| Mar 31, 2023 | -22.74% |
| Dec 31, 2022 | -22.20% |
| Sep 30, 2022 | -19.50% |
| Jun 30, 2022 | -16.28% |
| Mar 31, 2022 | -12.39% |
| Dec 31, 2021 | -8.54% |